Last Price
0.49
Today's Change
+0.01 (2.08%)
Day's Change
0.465 - 0.515
Trading Volume
5,917,421
Overview
Market Cap
273 Million
Shares Outstanding
557 Million
Avg Volume
2,001,386
Avg Price (50 Days)
0.36
Avg Price (200 Days)
0.41
PE Ratio
-12.25
EPS
-0.04
Earnings Announcement
24-Feb-2025
Previous Close
0.48
Open
0.47
Day's Range
0.465 - 0.515
Year Range
0.16 - 0.665
Trading Volume
5,917,421
Price Change Highlight
1 Day Change
2.08%
5 Day Change
42.03%
1 Month Change
38.03%
3 Month Change
28.95%
6 Month Change
7.69%
Ytd Change
31.54%
1 Year Change
60.66%
3 Year Change
60.66%
5 Year Change
60.66%
10 Year Change
60.66%
Max Change
60.66%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
